Retrospective Analysis of De-identified Deceased HCC Patients
Sponsor
Carr, Brian (Other)
Overall Status
Completed
CT.gov ID
NCT04477720
Collaborator
(none)
1,000
167
Study Details
Study Description
Brief Summary
De-identified deceased HCC patients who were not surgical candidates were evaluated for their clinical baseline characteristics associated with their survival. Baselines included tumor markers, blood counts and liver function tests and CAT-scan based tumor size and numbers and presence of portal vein thrombosis.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
1000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
HCC Observation Study
Actual Study Start Date
:
Jun 1, 1995
Actual Primary Completion Date
:
May 1, 2009
Actual Study Completion Date
:
May 1, 2009
Outcome Measures
Primary Outcome Measures
- Survival [10 years]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- biopsy-proven HCC
Exclusion Criteria:
- none
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Carr, Brian
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Carr, Brian
ClinicalTrials.gov Identifier:
NCT04477720
Other Study ID Numbers:
- BCarr
First Posted:
Jul 20, 2020
Last Update Posted:
Jul 20, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Carr, Brian